ASHP to Testify at House Hearing on Compounding

Published Online: Tuesday, July 16, 2013
Follow Pharmacy_Times:
PRESS RELEASE

July 16, 2013--ASHP is scheduled to testify today at a congressional hearing on reforming the regulatory framework of pharmacy compounding.
 
Kasey K. Thompson, Pharm.D.,  M.S., ASHP vice president of policy, planning, and communications, will represent the Society at the hearing called by the Health Subcommittee of the House Energy and Commerce Committee.
 
ASHP members are encouraged to email their House of Representatives member and ask for support of compounding legislation that establishes a clear jurisdictional boundary between the FDA and state boards of pharmacy.
 
The hearing will be broadcast at 3:00 p.m. on the Committee's website.
Related Articles
Unless you personally know a residency director, it’s difficult to connect with one. That’s where pharmacy conferences come in.
Fifteen hospitals that use insulin pens will participate in ASHP’s Mentored Quality Improvement Impact Program for Insulin Pen Safety.
ASHP is pleased to announce the selection of PharmAcademic from the McCreadie Group, Inc., to support the evaluation of residents and to provide documentation of a systems-based approach to training for ASHP-accredited residencies under the new, recently-approved PGY1 residency standard.
A New Jersey-based compounding pharmacy has voluntarily recalled 4 prescription preparations distributed in 4 states due to potential contamination.
Latest Issues
$auto_registration$